• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Coh

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 May 1;9(7):ofac223.
doi: 10.1093/ofid/ofac223. eCollection 2022 Jul.
Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study


Dennis Souverein[SUP] 1 [/SUP], Karlijn van Stralen[SUP] 2 [/SUP], Steven van Lelyveld[SUP] 2 [/SUP], Claudia van Gemeren[SUP] 2 [/SUP], Milly Haverkort[SUP] 3 [/SUP], Dominic Snijders[SUP] 2 [/SUP], Robin Soetekouw[SUP] 2 [/SUP], Erik Kapteijns[SUP] 4 [/SUP], Evelien de Jong[SUP] 4 [/SUP], Gonneke Hermanides[SUP] 4 [/SUP], Sem Aronson[SUP] 1 [/SUP], Bjorn Herpers[SUP] 1 [/SUP], Jeroen den Boer[SUP] 1 [/SUP], Alex Wagemakers[SUP] 1 [/SUP], Sjoerd Euser[SUP] 1 [/SUP]



Affiliations

Abstract

Background: We assessed the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and hospital admission, intensive care unit (ICU) admission, and in-hospital mortality.
Methods: All SARS-CoV-2-positive persons with a combined nasopharyngeal and oropharyngeal swab that was collected between 17 March 2020 and 31 March 2021 in public health testing facilities were included.
Results: From 20 207 SARS-CoV-2-positive persons, 310 (1.5%) were hospitalized within 30 days. High viral loads (crossing point [Cp] <25) were associated with an increased risk of hospitalization as compared to low viral loads (Cp >30), adjusted for age and sex (adjusted odds ratio [aOR], 1.57 [95% confidence interval {CI}, 1.11-2.26]). The same association was seen for ICU admission (aOR, 7.06 [95% CI, 2.15-43.57]). The median [interquartile range] Cp value of the 17 patients who died in hospital was significantly lower compared to the 226 survivors (22.7 [3.4] vs 25.0 [5.2]).
Conclusions: Higher initial SARS-CoV-2 viral load is associated with an increased risk of hospital admission, ICU admission, and in-hospital mortality. Our findings emphasize the added value of reporting SARS-CoV-2 viral load or cycle threshold/Cp values to identify persons who are at the highest risk of adverse outcomes such as hospital or ICU admission and who therefore may benefit from more intensive monitoring or early initiation of antiviral therapy.

Keywords: COVID-19; SARS-CoV-2; hospital admission; mortality; viral load distribution.
 
Back
Top Bottom